ArticleBMC infectious diseases2025
Adherence to national pediatric antibiotic prescription guideline for pneumonia treatment of children 2-59 months: a retrospective chart review at a regional hospital in Rwanda.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInappropriate use of antibiotics is a major driver of antimicrobial resistance and can lead to adverse healthcare outcomes. Treatment guidelines promote rational prescribing and help minimize healthcare costs. We aimed to assess adherence to the national pediatric treatment guideline for pneumonia among healthcare providers at a major rural hospital in Rwanda.
methodsA retrospective chart review was conducted to audit clinical records of children aged 2–59 months hospitalized with pneumonia between January 2022 to January 2024. Data on the classifications of pneumonia, prescribed medications, and adherence to the treatment protocol were extracted and analyzed. The local guideline’s classifications of pneumonia are in classes of stage based on severity of the disease. The World Health Organization/International Network of Rational Use of Drugs (WHO/INRUD) indicator parameters on adherence were used to summarize and present the results.
resultsClinical records from 308 patients generated by 30 doctors met the inclusion criteria. Only 42 (14%) of cases were correctly classified. While 558/781 (71%) prescriptions matched pneumonia signs and symptoms and were aligned with the guideline, adherence to the requirement for complete correct specification of the treatment regimen was 0/558 (0%). The route of administration, dose, frequency, and treatment duration were correct in only 366/558 (66%), 335/558 (60%), 251/558 (45%), and 67/558 (12%) of cases respectively. Once the medications were prescribed, 541/558 (97%) were administered according to the prescription.
conclusionAdherence to pneumonia treatment guideline was suboptimal, with major deficiencies in disease classification and treatment regimen implementation. The introduction of an antibiotic stewardship program to provide support through improved training and monitoring of antibiotic prescribing practices is warranted. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.